Endocrinología y nutrición

2024

1. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting

   Diabetes care, Vol. 47, Núm. 2, pp. 216-224

2. A Non-Secreting Pituitary Adenoma That Changed to a Prolactinoma

   Clinics and Practice, Vol. 14, Núm. 4, pp. 1310-1318

3. A cohort analysis of familial partial lipodystrophy from two Mediterranean countries

   Diabetes, Obesity and Metabolism, Vol. 26, Núm. 11, pp. 4875-4886

4. A newborn Screening Programme for Inborn errors of metabolism in Galicia: 22 years of evaluation and follow-up

   Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

5. A very-low-calorie ketogenic diet normalises obesity-related enhanced levels of erythropoietin compared with a low-calorie diet or bariatric surgery

   Journal of Endocrinological Investigation, Vol. 47, Núm. 11, pp. 2701-2713

6. Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients

   Life, Vol. 14, Núm. 7

7. Adherence and impact of an oral nutritional supplement enriched in leucine, EVOO, EPA and DHA, and beta-glucans on the coverage of energy and protein requirements in patients with cancer and malnutrition: Alisenoc study

   Nutrition, Vol. 120

8. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

   Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 575-586

9. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)

   Nature Reviews Endocrinology

10. Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain

    Advances in Therapy

11. Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 3, pp. e932-e944

12. Consenso del grupo de trabajo de los trastornos de la conducta alimentaria de SENPE (GTTCA-SENPE). Evaluación y tratamiento médico-nutricional en la anorexia nerviosa. Actualización 2023

    Nutricion hospitalaria, Vol. 41, Núm. 1, pp. 1-60

13. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows

    Endocrine Reviews, Vol. 45, Núm. 5, pp. 625-654

14. Consensus on criteria for acromegaly diagnosis and remission

    Pituitary, Vol. 27, Núm. 1, pp. 7-22

15. Consequences of the poor therapeutic adherence in diabetes mellitus and improvement recommendations

    Atencion Primaria Practica, Vol. 6, Núm. 4

16. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

17. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

18. Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis (Reviews in Endocrine and Metabolic Disorders, (2024), 25, 2, (447-448), 10.1007/s11154-023-09837-x)

    Reviews in Endocrine and Metabolic Disorders

19. Correction: consensus on criteria for acromegaly diagnosis and remission (Pituitary, (2024), 27, 1, (7-22), 10.1007/s11102-023-01360-1)

    Pituitary

20. Current barriers to initiating insulin therapy in individuals with type 2 diabetes

    Frontiers in Endocrinology, Vol. 15